Einstein On: Cardiovascular Disease, Dr. Richard Kitsis
Richard Kitsis, M.D., professor of medicine (cardiology) and of cell biology, the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease, and director of the Wilf Family Cardiovascular Research Institute, puts this devastating killer into sharp focus, detailing the causes, costs and research underway at Einstein. Interviewed by Einstein’s Gordon Earle. (Source: Einstein On...)
Source: Einstein On... - March 16, 2010 Category: Universities & Medical Training Authors: Albert Einstein College of Medicine Source Type: podcasts
International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network.
“To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world is a wonderful opportunity for ISCO. This partnership will lead to a significant expansion in ISCO’s revenue generation through the manufacture of high quality cells and cell culture products. Millipore is a leader in the life science industry, with a strong...
Source: International Stem Cell Corporation - September 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
The Lancet: October 05, 2007
Human papillomavirus DNA testing detects lesions which lead to cervical cancer earlier than conventional cytological techniques, and this early detection could lead to the extension of the current screening interval of five years by at least another year, comments Chris Meijer from VU Medical Centre, Amsterdam in this week's podcast. This extension would be advantageous to women because of a reduction in the lifetime number of screening tests and referrals. An accompanying Comment says that as well as being safe, such extended screening intervals will not only reduce the cost of screening and the burden for women, but ...
Source: Listen to The Lancet - October 5, 2007 Category: Journals (General) Authors: The Lancet Source Type: podcasts
ASFH Managing Stage 4 ROP
Guest: Jonathan E. Sears, M.D.Associate StaffDivision of Cell Biology and OphthalmologyCole Eye InstituteCleveland ClinicCleveland, OH (Source: As Seen From Here)
Source: As Seen From Here - June 3, 2007 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
Update on Pap tests
The launch of Australia's new vaccine for preventing certain strains of Human Papilloma Virus holds great promise in reducing the incidence of cervical cancer. But do we run the risk of missing tumors by slackening off on cervical cytology screening? Dr Stella Heley provides an update on Pap tests in this brave new world. (Source: Australian Family Physician audio)
Source: Australian Family Physician audio - February 28, 2007 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
ASFH Treating Submacular Hemorrhages with TPA
Paper Discussed: R P Singh, C Patel, and J E SearsManagement of subretinal macular haemorrhage by direct administration of tissue plasminogen activator British Journal of Ophthalmology 2006 April;90:429-431Guest: Jonathan E. Sears, M.D.Associate StaffDivision of Cell Biology and OphthalmologyCole Eye InstituteCleveland Clinic, Cleveland OH (Source: As Seen From Here)
Source: As Seen From Here - June 4, 2006 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
